13F Holdings
中文EN

JRSS JRSIS HEALTH CARE Corp

Services-Hospitals · OTC · SEC CIK 1597892 · Fiscal year ends 12/31

Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-100.5%
TTM EPS YoY-100.1%
Revenue 3-yr CAGR-52.4%
Net income 3-yr CAGR—

Margins

Gross margin9.4%
Operating margin-7.0%
Net margin-3.7%
FCF margin—
EBITDA margin-6.4%

Returns

ROE-125.7%
ROA-13.2%
ROIC (approx.)-171.2%
Asset turnover3.58x

Leverage & solvency

Liabilities / assets111.3%
Debt / equity—
Current ratio0.78x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.67x
Accruals ratio8.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2024Q32024-09-302024Q22024-06-302024Q12024-03-312023Q4*2023-12-312023Q32023-09-302023Q22023-06-302023Q12023-03-312022Q4*2022-12-31
Income statement
Revenue$222,922$597,396$500,420$3.41M$497,361$337,395$476,994—
Cost of revenue$196,037$411,284$443,198$1.98M$377,252$297,784$325,602—
Gross profit$26,885$186,112$57,222$171,939$120,109$39,611$151,392—
R&D expense$28,840$9,599$10,254$84,425$36,202$38,344$30,295—
SG&A expense$97,359$186,491$101,112$163,483$22,538$118,796$31,232—
Operating income-$206,190-$118,718-$160,906$154,704$51,011-$127,283$77,524-$43,820
Interest expense—$15,984$11,906——$14,018$19,738—
Pretax income-$219,970-$116,847-$169,948$257,689$39,284-$124,060$61,418-$45,561
Income tax$7$2,908—$918-$123-$103$8,283—
Net income-$188,146-$102,435-$145,356$262,390$33,705-$106,020$45,446$36.01M
EBITDA-$203,493-$116,079-$148,709$167,340$54,849-$122,858$91,927-$41,695
EPS (basic)-0.00-0.00-0.00—0.00-0.000.00—
EPS (diluted)-0.00-0.00-0.00—0.00-0.000.00—
Weighted avg. shares (diluted)84.60M84.60M84.33M—76.76M76.76M76.76M—
Balance sheet
Cash & equivalents$1,372$445,902$323,611$118,114$741$423,519$4,638$158,813
Receivables$575,205$555,837$603,022$714,658—$13,791—$683,452
Inventory$361,774$397,825$445,500$455,240———$562,015
Current assets$1.79M$1.83M$1.82M$1.83M$527,151$617,602$676,348$1.66M
PP&E, net$43,162$43,265$46,193$50,024$30,844$33,051$37,028$62,223
Intangibles$241,146$242,178$243,897$257,334———$303,195
Total assets$2.07M$2.11M$2.11M$2.14M$564,700$661,383$728,863$2.04M
Current liabilities$2.30M$2.11M$2.40M$2.28M$90,969$69,393$36,968$2.11M
Short-term debt$25,243$24,376$24,534$18,713———$49,709
Long-term debt$6,311$12,188$18,401$24,950————
Total debt$31,554$36,564$42,935$43,663————
Total liabilities$2.31M$2.13M$2.42M$2.31M$90,969$69,393$36,968$2.11M
Shareholders' equity-$197,594-$7,401-$259,933-$137,406$473,731$591,990$691,895-$58,453
Net debt$30,182-$409,338-$280,676-$74,451————
Shares outstanding84.60M84.60M84.60M82.59M5.84M5.84M58.37M76.76M
Cash flow statement
Operating cash flow-$352,266-$268,858-$204,937$536,904-$90,031$527,504-$16,507-$4.76M
Capital expenditure$67,633——$1,235-$358,535——-$1,723
Free cash flow-$419,899——$535,669$268,504——-$4.76M
Investing cash flow-$22——$19,134———$1,723
Financing cash flow-$95,807$402,570$413,267$7,877-$349,819-$83,248-$143,175$2.60M
Depreciation & amortization$2,697$2,639$12,197$12,636$3,838$4,425$14,403$2,125
Stock-based compensation————$81,822$81,822$81,821$81,822

Free plan shows the latest 8 periods; Pro shows all 43 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.